Global Acute Ischemic Stroke Diagnosis and Treatment Market Analysis, Drivers, Restraints, Opportunities, Threats, Trends, Applications, and Growth Forecast to 2028

“Global Acute Ischemic Stroke Diagnosis and Treatment Market Analysis Trends, Applications, Analysis, Growth, and Forecast to 2028” is a recent report generated by MarketResearch.biz. The global acute ischemic stroke diagnosis and treatment market report has been segmented on the basis of diagnosis type, surgery type, and region.

Request Covid - 19 Impact

Global Acute Ischemic Stroke Diagnosis and Treatment Market: Overview

Acute ischemic stroke is caused by rapid loss of several neurological function due to lack of blood supply to the brain. Acute ischemic functions are mainly caused by atherosclerosis plaques which blocks blood vessels, forms blood clots, and locks the blood distribution in arteries that nourishing the brain. It most commonly affects who are 60 aged and above and the risk and incidences of acute ischemic stroke increases with aging of individual. Quick treatment helps in improving chances of survival and may reduce complications. Acute ischemic stroke treatment depends on the type of stroke. Symptoms and signs may varies depending on the location of the occlusion and the extent of the collateral flow.

Global Acute Ischemic Stroke Diagnosis and Treatment Market: Dynamics

Increasing incidences of cardiovascular diseases is a key factors expected to drive the revenue growth of the target market over the forecast years. According to a World Health Organization report, around 17 Mn people die every year due to various types of cardiovascular diseases globally. In addition, increasing geriatric population, rising health care expenditure, technological advancement in surgical procedures, are some of the other factors expected to drive the growth of the global acute ischemic stroke diagnosis and treatment market. According to a report by the Aging World, the world aging population is expected to increase by 17% and reached to about 1.6 billion by 2050.

However, high cost of acute ischemic stroke diagnosis and treatment procedure and stringent regulatory approval by health authority are major factors expected to hamper the growth of the target market over the forecast period.

Global Acute Ischemic Stroke Diagnosis and Treatment Market: Trends

The prominent player in the target market are focusing on collaborating with other player and launching new products in the market. In addition, various players are focuses on receiving FDA and other health authority approvals. The aforementioned are some key trends witnessed in the target market, currently.

Global Acute Ischemic Stroke Diagnosis and Treatment Market: Regional Analysis

In 2018, the markets in North America is anticipated to account for largest revenue share in the target market. This is primarily due to favorable government policies, various technological innovations and advancement in healthcare sector in countries in the region. In addition, annually stroke cause to 1 out of every 20 deaths in US. The market in Asia Pacific is expected to gain highest growth rate over the forecast period, due to increasing elderly population and higher healthcare expenditure in countries in the region.  In addition, higher incidences of blood cholesterol, obesity, etc. and growing consumption of tobacco are some of the significant factors increasing ischemic strokes and is expected to support the growth of the Asia Pacific acute ischemic stroke diagnosis and treatment market.

Global Acute Ischemic Stroke Diagnosis and Treatment Market Segmentation:

Segmentation by diagnosis type:

• Computed Tomography
• Magnetic Resonance Imaging
• Ultrasound
• Cerebral Angiography
• Nuclear Imaging
• Others (includes Electrocardiography, Echocardiography, etc.)

 Segmentation by surgery type:

• Carotid Endarterectomy
• Angioplasty
• Endovascular Mechanical Thrombectomy

 Segmentation by region:

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East & Africa

• Abbott Laboratories
• Medtronic plc
• Boston Scientific Corporation
• Cordis Corporation
• Koninklijke Philips N.V.
• GE Healthcare
• Siemens AG
• Stryker Corporation
• Genentech, Inc.
• Merck & Co., Inc.